FT
Disputes leave AstraZeneca boss with chronic vaccine headache
Questions mount over whether Soriot’s dash and drive, which enthral investors, have resulted in missteps
Questions mount over whether Soriot’s dash and drive, which enthral investors, have resulted in missteps